Oxurion Announces Amendment to Funding Program with Negma
Leuven, BELGIUM, Boston, MA, US – September 2, 2022 – CET 10:30PM – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next...
Stay updated with breaking news from Tom Graney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leuven, BELGIUM, Boston, MA, US – September 2, 2022 – CET 10:30PM – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next...
Investegate announcements from Oxurion NV, Oxurion Announces Amendment to Funding Program with Negma Group for EUR 6 Million in Funding
Leuven, BELGIUM, Boston, MA, US - September 2, 2022 - CET 10:30PM - Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Negma Group has converted 200 convertible bonds in Oxurion resulting in a EUR 500,000 capital increase. This is part of Negma Group's EUR 30 million Capital Commitment1 that will allow Oxurion to